Discover the impact of CVE-2017-14111 in Philips IntelliSpace Cardiovascular (ISCV) and Xcelera versions. Learn about the vulnerability, affected systems, exploitation risks, and mitigation steps.
In Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier, as well as Xcelera R4.1L1 and previous versions, a vulnerability exists where the logging feature on workstations stores domain authentication credentials, potentially leading to unauthorized access.
Understanding CVE-2017-14111
This CVE identifies a security issue in Philips IntelliSpace Cardiovascular (ISCV) and Xcelera versions that could compromise user credentials.
What is CVE-2017-14111?
The vulnerability in ISCV and Xcelera versions allows malicious users to exploit stored domain authentication credentials, gaining unauthorized access to the application or other user privileges.
The Impact of CVE-2017-14111
The security flaw could result in unauthorized access to sensitive information, manipulation of data, or misuse of user privileges within the affected applications.
Technical Details of CVE-2017-14111
This section delves into the specific technical aspects of the vulnerability.
Vulnerability Description
The logging feature in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier, as well as Xcelera R4.1L1 and previous versions, stores domain authentication credentials, which if compromised, can be misused by attackers.
Affected Systems and Versions
Exploitation Mechanism
Attackers can exploit the stored domain authentication credentials to gain unauthorized access to the application or other user privileges, potentially leading to data breaches or unauthorized actions.
Mitigation and Prevention
Protective measures to mitigate the risks associated with CVE-2017-14111.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates
Ensure that the affected systems are updated with the latest patches and security fixes to mitigate the vulnerability effectively.